« April 2007 | Main | June 2007 »

May11
This is my last post for Pharmagazette

The last 14 months of blogging here at Pharmagazette had been rewarding in more ways than one and I want to take this opportunity to thank the whole Know More Media team for believing in me.

However, some things must end and after this post I will no longer be blogging for Pharmagazette.

(I will still be blogging about health and science though, but outside the Know More Media network of business blogs.)

While blogging about pharmaceutical business taught me huge stuff than I could ever learn somewhere else, it is something that I cannot do anymore. 

Thank you so much for frequenting this blog. I hope you still find time to visit when Know More Media finds a new resident blogger.  

And as for me, I will still be present in the blogosphere...so I hope you find me there some time soon. 

So long and best of luck and regards to Know More Media and its team of excellent professionals and wonderful people. 

May10
Interesting Finds: Pharma-related Posts 9
First Parkinson’s Disease Patch: Neupro®, Approved by the USFDA
May 8
USFDA Gave Final Approval to Lupin’s Cefdinir for Oral Suspension 250 mg/5 mL
U.S. Senate Blocked Efforts to Allow Prescription Drug Importation
Bayer Healthcare and Intendis Collaborates to Promote Yaz® for Moderate Acne Treatment
CTI’s Pixantrone Received USFDA Fast Track Status for Relapsed Indolent NHL
IR BioSciences’ Homspera Showing Potential as Influenza Vaccine Adjuvant in Studies
May 7
Abbott Seeks Approval of First Pediatric Indication for Humira®
May 6
Abbott’s Investigational Treatment ABT-874 Passed Phase II Psoriasis Study
May 5
First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer: FRAGMIN®, Approved by the USFDA
USFDA Awarded Orphan Drug Grant to Expression Genetics, Inc. for Clinical Development of EGEN-001 for Ovarian Cancer Treatment
May 4
Victory Pharma, Inc. Completed Acquisition of Naprelan®
License Agreement with Ingenuity Systems, Renewed and Expanded by Wyeth
Immediate Treatment of Betaseron® Significantly Delayed Permanent Disability in Early MS Patients
May 3
GSK’s Lamictal® XR™, Found Effective in Treatment of Partial Seizures
Interesting Finds: Pharma-related posts 8
May 2
Duramed's ENJUVIA™ Tablets Received Two New USFDA Approvals
CSL Behring’s Humate-P®, USFDA-Approved to Prevent Excessive Bleeding in Patients with von Willebrand Disease Undergoing Surgery
Of Summer Beach, Whalesharks and Spiderman 3

« April 2007 | Main | June 2007 »

Advertise

Watch the Digital Health Revolution


sponsored ads



Incredible Hall of Acclaim.

subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

WebMetricsGuru

TheInsurancePolicy

MarketingBlurb